LH
Price:
$261.48
Market Cap:
$21.68B
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Industry
Medical - Equipment & Services
IPO Date
1990-03-29
Stock Exchange
NYSE
Ticker
LH
According to Labcorp Holdings Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 25.69. This represents a change of 0.59% compared to the average of 25.54 of the last 4 quarters.
The mean historical PE Ratio of Labcorp Holdings Inc. over the last ten years is 18.97. The current 25.69 PE Ratio has changed 13.44% with respect to the historical average. Over the past ten years (40 quarters), LH's PE Ratio was at its highest in in the December 2022 quarter at 58.81. The PE Ratio was at its lowest in in the December 2023 quarter at -28.87.
Average
18.97
Median
14.92
Minimum
10.93
Maximum
47.36
Discovering the peaks and valleys of Labcorp Holdings Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 228.73%
Maximum Annual PE Ratio = 47.36
Minimum Annual Increase = -45.54%
Minimum Annual PE Ratio = 10.93
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 25.79 | -45.54% |
| 2023 | 47.36 | 228.73% |
| 2022 | 14.41 | 31.22% |
| 2021 | 10.98 | 0.42% |
| 2020 | 10.93 | -36.69% |
| 2019 | 17.27 | 38.66% |
| 2018 | 12.46 | 12.57% |
| 2017 | 11.06 | -28.35% |
| 2016 | 15.44 | -35.72% |
| 2015 | 24.02 | 56.22% |
The current PE Ratio of Labcorp Holdings Inc. (LH) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
29.19
5-year avg
21.89
10-year avg
18.97
Labcorp Holdings Inc.’s PE Ratio is less than Waters Corporation (36.37), greater than Quest Diagnostics Incorporated (21.29), greater than Zimmer Biomet Holdings, Inc. (22.92), less than West Pharmaceutical Services, Inc. (41.43), less than Illumina, Inc. (28.41), less than DexCom, Inc. (35.41), less than STERIS plc (37.30), greater than Biogen Inc. (16.59), greater than Incyte Corporation (16.54), greater than United Therapeutics Corporation (16.67),
| Company | PE Ratio | Market cap |
|---|---|---|
| 36.37 | $23.60B | |
| 21.29 | $20.58B | |
| 22.92 | $18.46B | |
| 41.43 | $20.27B | |
| 28.41 | $19.56B | |
| 35.41 | $25.53B | |
| 37.30 | $25.68B | |
| 16.59 | $26.70B | |
| 16.54 | $19.72B | |
| 16.67 | $21.63B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Labcorp Holdings Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Labcorp Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Labcorp Holdings Inc.'s PE Ratio?
How is the PE Ratio calculated for Labcorp Holdings Inc. (LH)?
What is the highest PE Ratio for Labcorp Holdings Inc. (LH)?
What is the 3-year average PE Ratio for Labcorp Holdings Inc. (LH)?
What is the 5-year average PE Ratio for Labcorp Holdings Inc. (LH)?
How does the current PE Ratio for Labcorp Holdings Inc. (LH) compare to its historical average?